Slit2 promotes tumor growth and invasion in chemically induced skin carcinogenesis

Cuiling Qi1, Haimei Lan2, Jie Ye1

  • 1Vascular Biology Research Institute, Guangdong Pharmaceutical University, Guangzhou, China.

Insights

Slit2 protein accelerates skin tumor development and invasion in mice by increasing cell proliferation, blood vessel formation, and matrix metalloproteinase-2 (MMP2) expression, leading to basement membrane degradation.

Area of Science:

  • Oncology
  • Cell Biology
  • Dermatology

Background:

  • Slit proteins, acting as guidance cues, regulate cell migration and are implicated in tumor progression.
  • The role of Slit2 in skin tumorigenesis and invasion requires further elucidation.

Purpose of the Study:

  • To investigate the function of Slit2 in chemical-induced skin tumor growth and invasion in mice.
  • To elucidate the underlying molecular mechanisms by which Slit2 influences skin carcinogenesis.

Main Methods:

  • A two-step chemical carcinogenesis protocol in wild-type and Slit2-transgenic (Slit2-Tg) mice.
  • Analysis of tumor incidence, size, proliferation (BrdU incorporation), microvessel density, basement membrane integrity (PAS and type IV collagen staining), and matrix metalloproteinase (MMP) expression (MMP2 and MMP9).
  • In vitro assessment of squamous cell carcinoma cell invasion upon interruption of Slit2-Robo1 signaling.

Main Results:

  • Slit2 expression correlated with basement membrane loss in human skin squamous cell carcinoma.
  • Slit2-Tg mice exhibited increased skin tumor development, larger tumor size, and accelerated pathological progression compared to wild-type mice.
  • Elevated cell proliferation, microvessel density, and upregulation of MMP2 were observed in Slit2-Tg mice, alongside basement membrane degradation.

Conclusions:

  • Slit2 significantly promotes 7,12-dimethylbenz[a]anthracene/12-O-tetradecanoylphorbol-13-acetate (DMBA/TPA)-induced skin tumorigenesis.
  • Slit2 enhances tumor growth and invasion by increasing cell proliferation, angiogenesis, and MMP2 expression, which contributes to basement membrane breakdown.
  • Targeting Slit2-Robo1 signaling may represent a therapeutic strategy for cutaneous squamous cell carcinoma.